A fixed-dose combination of adapalene 0.1%–BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne

Author: Brodell Robert T.   Schlosser Bethanee J.   Rafal Elyse   Toth Darryl   Tyring Stephen   Wertheimer Albert   Kerrouche Nabil   Bucher Delphine  

Publisher: Informa Healthcare

ISSN: 1471-1753

Source: Journal of Dermatological Treatment, Vol.23, Iss.1, 2012-02, pp. : 26-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content